Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

By B. Lagerqvist, S. James, U. Stenestrand, J. Lindbäck, T. Nilsson, L. Wallentin. New England Journal of Medicine, 2007

1,310 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction Patients: An Autopsy Study (2008, neutral): “... 5711 0.80 Male gender, n (%) 14 (82) 16 (89) 0.33 Stent duration, d* 270 (65–465) 315 (113–570) 0.36 Diseased vessels, n* 2 (2–3) 3 (1–3) 0.91 Cypher/Taxus, n 7/10 9/9 0.60 No. of stents* 1 (1–2) 1 (1–1.25) 0.46 Stent length, mm* 22.0 (20.0–44.0) 22.0 (15.3–32.3) 0.16 Stent length 30 mm, n (%) 6”
ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiov (2007, background): “6033 patients treated with DES and 13 738 patients treated with bare-metal stents and followed up for 3 years (341).”